| pubmed-article:11296098 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11296098 | lifeskim:mentions | umls-concept:C2926606 | lld:lifeskim |
| pubmed-article:11296098 | lifeskim:mentions | umls-concept:C0008328 | lld:lifeskim |
| pubmed-article:11296098 | lifeskim:mentions | umls-concept:C0027481 | lld:lifeskim |
| pubmed-article:11296098 | lifeskim:mentions | umls-concept:C2607943 | lld:lifeskim |
| pubmed-article:11296098 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:11296098 | lifeskim:mentions | umls-concept:C0086769 | lld:lifeskim |
| pubmed-article:11296098 | lifeskim:mentions | umls-concept:C0439611 | lld:lifeskim |
| pubmed-article:11296098 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11296098 | pubmed:dateCreated | 2001-4-11 | lld:pubmed |
| pubmed-article:11296098 | pubmed:abstractText | Panic attacks induced by administration of cholecystokinin tetrapeptide (CCK-4) have been evaluated as a valuable tool to investigate the neurobiological mechanisms involved in panic anxiety. The rationale to study the effects of natriuretic peptides on the CCK-4 response is derived from observations that atrial natriuretic peptide (ANP) is released during panic attacks in humans and has anxiolyticlike actions in various animal models. | lld:pubmed |
| pubmed-article:11296098 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11296098 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11296098 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11296098 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11296098 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11296098 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11296098 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11296098 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11296098 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11296098 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11296098 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:11296098 | pubmed:issn | 0003-990X | lld:pubmed |
| pubmed-article:11296098 | pubmed:author | pubmed-author:KellnerMM | lld:pubmed |
| pubmed-article:11296098 | pubmed:author | pubmed-author:WiedemannKK | lld:pubmed |
| pubmed-article:11296098 | pubmed:author | pubmed-author:JahnHH | lld:pubmed |
| pubmed-article:11296098 | pubmed:author | pubmed-author:YassouridisAA | lld:pubmed |
| pubmed-article:11296098 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11296098 | pubmed:volume | 58 | lld:pubmed |
| pubmed-article:11296098 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11296098 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11296098 | pubmed:pagination | 371-7 | lld:pubmed |
| pubmed-article:11296098 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:meshHeading | pubmed-meshheading:11296098... | lld:pubmed |
| pubmed-article:11296098 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11296098 | pubmed:articleTitle | Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings. | lld:pubmed |
| pubmed-article:11296098 | pubmed:affiliation | Department of Psychiatry and Psychotherapy, University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany. wiedeman@uke.uni-hamburg.de | lld:pubmed |
| pubmed-article:11296098 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11296098 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11296098 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11296098 | lld:pubmed |
